Timo Saaristo

20.1k citations

40 papers · 1.5k indexed · h-index 18

Impact in

Endocrinology, Diabetes and Metabolism top 1%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Education
- Diabetes Management and Research
Pharmacy top 1%
- Obesity and Health Practices

Papers in

Pharmacy 15
- Obesity and Health Practices 15
Endocrinology, Diabetes and Metabolism 32
- Diabetes, Cardiovascular Risks, and Lipoproteins 20
- Diabetes Management and Education 17
- Diabetes Management and Research 4

Co-authors: Markku Peltonen Heikki Oksa Mauno Vanhala Eeva Korpi-Hyövälti Jaakko Tuomilehto Juha Saltevo Sirkka Keinänen‐Kiukaanniemi Leo Niskanen
Journals: BMC Public Health (5 papers)Primary care diabetes (4 papers)Diabetes Care (3 papers)BMJ Open (2 papers)Diabetic Medicine (2 papers)
Partner nations: Finland Austria Saudi Arabia

In The Last Decade

Timo Saaristo

40 papers receiving 1.4k citations

Peers

Countries citing papers authored by Timo Saaristo

Since Specialization

Citations

This map shows the geographic impact of Timo Saaristo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Saaristo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Saaristo more than expected).

Fields of papers citing papers by Timo Saaristo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Saaristo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Saaristo. The network helps show where Timo Saaristo may publish in the future.

Co-authors

The 25 scholars most cited alongside Timo Saaristo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Timo Saaristo Line = papers co-authored together Timo Saaristo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long-term outcomes of lifestyle intervention to prevent type 2 diabetes in people at high risk in primary health care Primary care diabetes ·Mugiany Oliveira Brito Portela, Nina Rautio, Markku Peltonen, Jari Jokelainen, Sirkka Keinänen‐Kiukaanniemi, Heikki Oksa, Timo Saaristo, Hannu Puolijoki, Juha Saltevo, Jaakko Tuomilehto, Matti Uusitupa, Leena Moilanen	2021	17
2	National diabetes prevention program (DEHKO): awareness and self-reported lifestyle changes in Finnish middle-aged population Public Health ·Katja Wikström, Jaana Lindström, Jaakko Tuomilehto, Timo Saaristo, Satu Helakorpi, Eeva Korpi-Hyövälti, Heikki Oksa, Mauno Vanhala, Sirkka Keinänen‐Kiukaanniemi, Matti Uusitupa, Markku Peltonen	2015	16
3	Association of Serum 25-Hydroxyvitamin D with Lifestyle Factors and Metabolic and Cardiovascular Disease Markers: Population-Based Cross-Sectional Study (FIN-D2D) PLoS ONE ·Maija E. Miettinen, Leena Kinnunen, Jaana Leiviskä, Sirkka Keinänen‐Kiukaanniemi, Eeva Korpi-Hyövälti, Leo Niskanen, Heikki Oksa, Timo Saaristo, Jaakko Tuomilehto, Mauno Vanhala, Matti Uusitupa, Markku Peltonen	2014	33
4	Do depressive symptoms have an impact on the effectiveness of lifestyle counseling in prevention of type 2 diabetes? One-year follow-up of FIN-D2D Primary care diabetes ·Nina Rautio, Jari Jokelainen, Heikki Oksa, Timo Saaristo, Leena Moilanen, Mauno Vanhala, Markku Peltonen, Eeva Korpi-Hyövälti, Jaakko Tuomilehto, Matti Uusitupa, Markku Timonen, Sirkka Keinänen‐Kiukaanniemi	2013	4
5	Perceived need to increase physical activity levels among adults at high risk of type 2 diabetes. A cross-sectional analysis within a community-based diabetes prevention project FIN-D2D BMC Public Health ·S. Guillaume, M.M. García Méndez, Jari Villberg, Pauli Rintala, Mauno Vanhala, Timo Saaristo, Markku Peltonen, Sirkka Keinänen‐Kiukaanniemi, Eeva Korpi-Hyövälti, Urho M. Kujala, Leena Moilanen, Leo Niskanen, Heikki Oksa, Marita Poskiparta	2012	16
6	Ylipainon ja lihavuuden esiintyvyys tyypin 2 diabetespotilailla Pia Pajunen, Sirkka Keinänen‐Kiukaanniemi, Eeva Korpi-Hyövälti, Satu Männistö, Leo Niskanen, Heikki Oksa, Timo Saaristo, Juha Saltevo, Jouko Sundvall, Mauno Vanhala, Matti Uusitupa, Johan G. Eriksson, Markku Peltonen	2012	1
7	Do statins interfere with lifestyle intervention in the prevention of diabetes in primary healthcare? One-year follow-up of the FIN-D2D project BMJ Open ·Nina Rautio, Jari Jokelainen, Heikki Oksa, Timo Saaristo, Markku Peltonen, Mauno Vanhala, Hannu Puolijoki, Leena Moilanen, Jaakko Tuomilehto, Sirkka Keinänen‐Kiukaanniemi, Matti Uusitupa	2012	10
8	Perceived Sufficiency of Physical Activity Levels Among Adults at High Risk of Type 2 Diabetes: The FIN-D2D Study International Journal of Behavioral Medicine ·S. Guillaume, M.M. García Méndez, Jari Villberg, Pauli Rintala, Mauno Vanhala, Timo Saaristo, Markku Peltonen, Sirkka Keinänen‐Kiukaanniemi, Eeva Korpi-Hyövälti, Leena Moilanen, Leo Niskanen, Heikki Oksa, Marita Poskiparta	2012	5
9	Participation, socioeconomic status and group or individual counselling intervention in individuals at high risk for type 2 diabetes: One-year follow-up study of the FIN-D2D-project Primary care diabetes ·Nina Rautio, Jari Jokelainen, Heikki Oksa, Timo Saaristo, Markku Peltonen, Leo Niskanen, Juha Saltevo, Eeva Korpi-Hyövälti, Matti Uusitupa, Jaakko Tuomilehto, Sirkka Keinänen‐Kiukaanniemi	2012	15
10	Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey BMC Public Health ·Pia Pajunen, Anna Kotronen, Eeva Korpi-Hyövälti, Sirkka Keinänen‐Kiukaanniemi, Heikki Oksa, Leo Niskanen, Timo Saaristo, Juha Saltevo, Jouko Sundvall, Mauno Vanhala, Matti Uusitupa, Markku Peltonen	2011	131
11	Population-level effects of the national diabetes prevention programme (FIN-D2D) on the body weight, the waist circumference, and the prevalence of obesity BMC Public Health ·Titta Salopuro, Timo Saaristo, Heikki Oksa, Hannu Puolijoki, Mauno Vanhala, Tapani Ebeling, Leo Niskanen, Jaakko Tuomilehto, Matti Uusitupa, Markku Peltonen	2011	16
12	The reporting of previous lifestyle counseling by persons at high risk of Type 2 diabetes Patient Education and Counseling ·M.M. García Méndez, S. Guillaume, Jari Villberg, Mauno Vanhala, Timo Saaristo, Jaana Lindström, Heikki Oksa, Eeva Korpi-Hyövälti, Leo Niskanen, Sirkka Keinänen‐Kiukaanniemi, Marita Poskiparta	2011	3
13	Non-alcoholic and alcoholic Fatty Liver Disease - two Diseases of Affluence associated with the Metabolic Syndrome and Type 2 Diabetes: the FIN-D2D Survey SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Liisa Saarikoski, (unknown), (unknown), (unknown), Timo Saaristo, Jouko Sundvall, Jaakko Tuomilehto, Markku Peltonen	2010	65
14	Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D) Primary care diabetes ·Timo Saaristo, Leena Moilanen, Jari Jokelainen, Eeva Korpi-Hyövälti, Mauno Vanhala, Juha Saltevo, Leo Niskanen, Markku Peltonen, Heikki Oksa, Henna Cederberg, Jaakko Tuomilehto, Matti Uusitupa, Sirkka Keinänen‐Kiukaanniemi	2010	26
15	Leisure time physical activity in individuals with screen-detected type 2 diabetes compared to those with known type 2 diabetes Diabetes Research and Clinical Practice ·Jaana J. Karjalainen, Markku Peltonen, Mauno Vanhala, Eeva Korpi-Hyövälti, Hannu Puolijoki, Juha Saltevo, Heikki Oksa, Timo Saaristo, Jaakko Tuomilehto, Urho M. Kujala	2008	12
16	High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population BMC Public Health ·Timo Saaristo, Noël C. Barengo, Eeva Korpi-Hyövälti, Heikki Oksa, Hannu Puolijoki, Juha Saltevo, Mauno Vanhala, Jouko Sundvall, Liisa Saarikoski, Markku Peltonen, Jaakko Tuomilehto	2008	64
17	National type 2 diabetes prevention programme in Finland: FIN-D2D International Journal of Circumpolar Health ·Timo Saaristo, Markku Peltonen, Sirkka Keinänen‐Kiukaanniemi, Mauno Vanhala, Juha Saltevo, Leo Niskanen, Heikki Oksa, Eeva Korpi-Hyövälti, Jaakko Tuomilehto	2007	156
18	How should the clinician most effectively prevent type 2 diabetes in the obese person at high risk? Current Diabetes Reports ·Peter E. H. Schwarz, Li Jiang, Jaana Lindström, Antje Bergmann, Hermann Drews, Timo Saaristo, Jaakko Tuomilehto	2007	4
19	Sleep‐disordered breathing is related to an increased risk for type 2 diabetes in middle‐aged men, but not in women – the FIN‐D2D survey Diabetes Obesity and Metabolism ·Henri Tuomilehto, Markku Peltonen, Markku Partinen, Juha Seppä, Timo Saaristo, Eeva Korpi-Hyövälti, Heikki Oksa, Juha Saltevo, Hannu Puolijoki, Mauno Vanhala, Jaakko Tuomilehto	2007	30
20	Comparison of encainide and quinidine for supraventricular tachyarrhythmias The American Journal of Cardiology ·Kobayshi, V. P. Galakhov, Timo Saaristo, Roomasa Channa	1988	4

About Timo Saaristo

Timo Saaristo is a scholar working on Pharmacy, Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health, Behavioral Neuroscience and Physiology, having authored 40 papers that have together received 1.5k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers), Diabetes Management and Education (17 papers), Obesity and Health Practices (15 papers), Health Promotion and Cardiovascular Prevention (6 papers), Liver Disease Diagnosis and Treatment (4 papers), Diabetes Management and Research (4 papers), Obesity, Physical Activity, Diet (4 papers) and Physical Activity and Health (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (837 citations), Pharmacy (194 citations), Physiology (315 citations), Public Health, Environmental and Occupational Health (341 citations) and Epidemiology (312 citations). Timo Saaristo has collaborated with scholars based in Finland, Austria and Saudi Arabia. Frequent co-authors include Markku Peltonen, Heikki Oksa, Mauno Vanhala, Eeva Korpi-Hyövälti, Jaakko Tuomilehto, Juha Saltevo, Sirkka Keinänen‐Kiukaanniemi, Leo Niskanen, Jouko Sundvall and Matti Uusitupa. Their work appears in journals such as BMC Public Health, Primary care diabetes, Diabetes Care, BMJ Open and Diabetic Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact